On Tuesday we’ll hop on BART to go down to the Hyatt Regency San Francisco for a portion of Fierce JPM Week. Our coverage ...

Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and generalized myasthenia gravis (gMG) in ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

A new study from the University of Iowa finds that many drug prices actually drop after pharmaceutical company mergers, ...

The drug was first approved in the 1990s and is currently marketed by Eli Lilly under the brand name Zyprexa. Teva, which launched a Dr. Reddy’s-partnered generic to Zyprexa in 2011, spotted a ...

Eli Lilly partners with VC to launch 700 billion won biotech ecosystem fund Eli Lilly collaborates with a16z to create a vast ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

While leading treatments known as GLP-1 drugs from Novo Nordisk and Eli Lilly are both injectables, the Hansoh drug can be taken orally. Other companies, such as Amgen and Structure Therapeutics ...

Hikma's branded generic will compete with Teva Pharmaceuticals (TEVA.TA), opens ... once-weekly treatments such as Novo's Ozempic and Eli Lilly's (LLY.N), opens new tab Mounjaro.

Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format KELOWNA, BC / ACCESSWIRE / January 15, 2025 / Lexaria B ...

New York, New York-- (Newsfile Corp. - January 12, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

BFA Law Announces that a Class Action has been filed against BioAge Labs, Inc. - Contact the Firm if You Suffered Losses ...